Drugs Made in America Acquisition Corp.’s Quiet Period Will Expire on March 10th (NASDAQ:DMAAU)

Drugs Made in America Acquisition’s (NASDAQ:DMAAU) quiet period is set to end on Monday, March 10th. Drugs Made in America Acquisition had issued 20,000,000 shares in its IPO on January 28th. The total size of the offering was $200,000,000 based on an initial share price of $10.00. During the company’s quiet period, insiders and underwriters that worked on the IPO are restricted from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company’s quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

Drugs Made in America Acquisition Stock Up 0.2 %

Shares of DMAAU opened at $10.13 on Friday. Drugs Made in America Acquisition has a 12 month low of $10.00 and a 12 month high of $10.82.

Drugs Made in America Acquisition Company Profile

Drugs Made In America Acquisition Corp. is a blank check company newly incorporated in the Cayman Islands as an exempted company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses.